JavaScript is required for full functionality of this site, including analytics.

iCardio.ai

iCardio.ai empowers clinicians with FDA-cleared AI to automate and enhance echocardiography interpretation for faster, more accurate cardiac diagnostics.

iCardio.ai screenshot

Category: AI Detection

Price Model: Freemium

Audience: Business

Trustpilot Score: N/A

Trustpilot Reviews: N/A

Our Review

iCardio.ai: Revolutionizing Echocardiography with AI-Powered Precision

iCardio.ai is a cutting-edge AI toolset designed to transform echocardiography by automating ultrasound interpretation with clinically validated machine learning and deep learning algorithms. Specializing in transthoracic echocardiography, it leverages a vast database of over 200 million de-identified images to deliver accurate, real-time diagnostic support across diverse healthcare environments. The platform is ideal for clinicians, institutions, and enterprises seeking to improve efficiency, accuracy, and accessibility in cardiac imaging—especially in point-of-care settings where specialist expertise may be limited. With FDA 510(k) clearance for EchoMeasure™ and Breakthrough Device Designation for CardioVision™, iCardio.ai stands at the forefront of AI-driven cardiovascular diagnostics.

Key Features:

  • EchoMeasure™ (FDA 510(k) Cleared): Automated echocardiographic interpretation with image perspective classification, image quality assessment, and over a dozen linear and volumetric measurements.
  • CardioVision™ (FDA Breakthrough Designation): Advanced AI system for detecting moderate and severe aortic stenosis using handheld ultrasound devices, enabling early diagnosis and improved patient outcomes.
  • Automated Ejection Fraction Prediction: Instant, accurate estimation of ejection fraction to support cardiac function assessment.
  • Feature Extraction and Navigation: Intelligent identification and guidance through key cardiac structures in real time.
  • LVOT and Aortic Diameter Measurement: Precise automated measurements critical for diagnosing valvular heart disease.
  • Real-Time View Classification: Uses MobileNet model architecture to instantly classify cardiac views (e.g., PLAX) during imaging.
  • Automated Reporting: Streamlines workflow with AI-generated, clinically relevant reports.
  • Integration with PACS Systems: Seamlessly works within UltraLinQ and other enterprise imaging platforms for efficient clinical adoption.
  • Support for Point-of-Care Ultrasound (POCUS): Empowers non-specialists with reliable, standardized diagnostic tools in underserved or resource-limited settings.
  • Data-Driven Innovation: Built on a massive dataset of 200 million de-identified echocardiographic images, ensuring robust model training and generalizability.

Pricing: iCardio.ai offers a freemium model, providing foundational AI tools for initial evaluation and integration, with premium features and enterprise licensing available through direct consultation.

Conclusion: iCardio.ai is a transformative AI solution for echocardiography, combining regulatory validation, advanced deep learning, and real-world clinical integration to enhance cardiac care accessibility, accuracy, and efficiency—making it a vital asset for modern cardiology workflows.

You might also like...

us2.ai screenshot

us2.ai empowers healthcare providers with real-time, expert-level echocardiogram analysis through AI, making cardiac diagnostics faster and more accessible.

.........
InHEART screenshot

InHEART provides AI-powered cardiac digital twins to enhance image-guided ablations with precision and efficiency.

......
idoven.ai screenshot

idoven.ai delivers AI-powered, cardiologist-level ECG analysis for early cardiac diagnosis and pharmaceutical monitoring.

.........